Nemucore Medical Innovations Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $92.3K

  • Investors
  • 3

Nemucore Medical Innovations General Information

Description

Operator of a clinical development company intended to offer molecularly-targeted nanomedicines. The company's clinical development services include the development and commercialization of NMI-900 a life-saving molecularly-targeted therapeutic which is an aurora B Kinase inhibitor that evades cancer defenses and delivers medications that can treat tumors, enabling cancer patients to treat newly diagnosed, recurrent, and multi-drug resistant cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Hollis Street
  • Suite 232
  • Wellesley, MA 02482
  • United States
+1 (508)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • One Hollis Street
  • Suite 232
  • Wellesley, MA 02482
  • United States
+1 (508)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nemucore Medical Innovations Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Equity Crowdfunding 30-Apr-2018 $92.3K Completed Generating Revenue
7. Grant 31-Jan-2016 Completed Generating Revenue
6. Later Stage VC (Series A) 07-Dec-2015 Completed Generating Revenue
5. Grant 31-Jul-2015 Completed Generating Revenue
4. Grant 01-Jan-2013 Completed Generating Revenue
3. Grant 31-Aug-2012 Completed Generating Revenue
2. Accelerator/Incubator 10-Apr-2012 Completed Generating Revenue
1. Grant 01-Jan-2010 $302K Completed Generating Revenue
To view Nemucore Medical Innovations’s complete valuation and funding history, request access »

Nemucore Medical Innovations Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Nemucore Medical Innovations’s complete cap table history, request access »

Nemucore Medical Innovations Patents

Nemucore Medical Innovations Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220218831-A1 Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand Inactive 01-May-2019
CA-3138517-A1 Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand Pending 01-May-2019
EP-3962480-A1 Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand Inactive 01-May-2019
EP-3962480-A4 Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand Inactive 01-May-2019
US-20170275319-A1 Platinum derivatives for hydrophobic formulations Inactive 25-Jul-2013 C07F15/0093
To view Nemucore Medical Innovations’s complete patent history, request access »

Nemucore Medical Innovations Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nemucore Medical Innovations Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boynton Angels Angel Group Minority
Massachusetts Biomedical Initiatives Accelerator/Incubator
U.S. Department of Health and Human Services Government
To view Nemucore Medical Innovations’s complete investors history, request access »

Nemucore Medical Innovations FAQs

  • When was Nemucore Medical Innovations founded?

    Nemucore Medical Innovations was founded in 2008.

  • Where is Nemucore Medical Innovations headquartered?

    Nemucore Medical Innovations is headquartered in Wellesley, MA.

  • What is the size of Nemucore Medical Innovations?

    Nemucore Medical Innovations has 6 total employees.

  • What industry is Nemucore Medical Innovations in?

    Nemucore Medical Innovations’s primary industry is Drug Discovery.

  • Is Nemucore Medical Innovations a private or public company?

    Nemucore Medical Innovations is a Private company.

  • What is Nemucore Medical Innovations’s current revenue?

    The current revenue for Nemucore Medical Innovations is .

  • How much funding has Nemucore Medical Innovations raised over time?

    Nemucore Medical Innovations has raised $1.09M.

  • Who are Nemucore Medical Innovations’s investors?

    Boynton Angels, Massachusetts Biomedical Initiatives, and U.S. Department of Health and Human Services have invested in Nemucore Medical Innovations.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »